United Kingdom - English - VMD (Veterinary Medicines Directorate)

intervet uk ltd - bordetella bronchiseptica, pasteurella multocida -

European Union - English - EMA (European Medicines Agency)

intervet international bv - protein do (non-toxic deletion derivative of pasteurella multocida dermonecrotic toxin), inactivated bordetella bronchiseptica cells - immunologicals for suidae - pigs (gilts and sows) - for the reduction of clinical signs of progressive atrophic rhinitis in piglets by passive oral immunisation with colostrum from dams actively immunised with the vaccine.

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - bordetella bronchiseptica, pasteurella multocida - suspension for injection - inactivated bacterial vaccine - pigs

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer, recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals, - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.,

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - actinobacillus pleuropneumoniae rtx toxine iii (apxiii) 50 u/dose; actinobacillus pleuropneumoniae rtx toxine i (apxi) 50 u/dose; actinobacillus pleuropneumoniae outer membrane protein (omp) 50 u/dose; actinobacillus pleuropneumoniae rtx toxine ii (apxii) 50 u/dose - solution for injection - actinobacillus pleuropneumoniae 600 mg - bordetella + pasteurella - pig

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - bordetella bronchiseptica (inactivated) ; pasteurella multocida d0 protein - emulsion for injection - pasteurella multocida; bordetella bronchiseptica - bordetella + pasteurella - pig

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international - bordetella bronchiseptica (inactivated) = 8,0 log2/do agglutiantietiter; pasteurella multocida d0 protein = 4,0 log2/dose toxin-neutralising antibody titre - emulsion for injection - pasteurella multocida anatoxine; pasteurella multocida; bordetella bronchiseptica - bordetella + pasteurella - pig

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium - pasteurella multocida; pasteurella multocida anatoxine; bordetella bronchiseptica - suspension for injection - pasteurella multocida; pasteurella multocida anatoxine; bordetella bronchiseptica - bordetella + pasteurella - pig

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - actinobacillus pleuropneumoniae rtx toxine iii (apxiii) 50 u/dose; actinobacillus pleuropneumoniae rtx toxine i (apxi) 50 u/dose; actinobacillus pleuropneumoniae outer membrane protein (omp) 50 u/dose; actinobacillus pleuropneumoniae rtx toxine ii (apxii) 50 u/dose - solution for injection - bordetella + pasteurella